172 related articles for article (PubMed ID: 22718313)
1. In planta production of a candidate vaccine against bovine papillomavirus type 1.
Love AJ; Chapman SN; Matic S; Noris E; Lomonossoff GP; Taliansky M
Planta; 2012 Oct; 236(4):1305-13. PubMed ID: 22718313
[TBL] [Abstract][Full Text] [Related]
2. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector.
Varsani A; Williamson AL; Stewart D; Rybicki EP
Virus Res; 2006 Sep; 120(1-2):91-6. PubMed ID: 16530873
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine.
Módolo DG; Araldi RP; Mazzuchelli-de-Souza J; Pereira A; Pimenta DC; Zanphorlin LM; Beçak W; Menossi M; de Cassia Stocco R; de Carvalho RF
Vaccine; 2017 Mar; 35(12):1590-1593. PubMed ID: 28222997
[TBL] [Abstract][Full Text] [Related]
4. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
Pineo CB; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
[TBL] [Abstract][Full Text] [Related]
6. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of plant-produced porcine circovirus-like particles in mice.
Gunter CJ; Regnard GL; Rybicki EP; Hitzeroth II
Plant Biotechnol J; 2019 Sep; 17(9):1751-1759. PubMed ID: 30791210
[TBL] [Abstract][Full Text] [Related]
8. Assembly and Purification of Polyomavirus-Like Particles from Plants.
Catrice EV; Sainsbury F
Mol Biotechnol; 2015 Oct; 57(10):904-13. PubMed ID: 26179381
[TBL] [Abstract][Full Text] [Related]
9. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
[TBL] [Abstract][Full Text] [Related]
10. Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana.
Regnard GL; Rybicki EP; Hitzeroth II
Virol J; 2017 Sep; 14(1):174. PubMed ID: 28893289
[TBL] [Abstract][Full Text] [Related]
11. Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.
Harnacker J; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Brandt S
J Gen Virol; 2017 Jun; 98(6):1329-1333. PubMed ID: 28635592
[TBL] [Abstract][Full Text] [Related]
12. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
Noris E
Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
[TBL] [Abstract][Full Text] [Related]
14. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
15. Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
Diamos AG; Larios D; Brown L; Kilbourne J; Kim HS; Saxena D; Palmer KE; Mason HS
Vaccine; 2019 Jan; 37(1):137-144. PubMed ID: 30459071
[TBL] [Abstract][Full Text] [Related]
16. Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.
Zahin M; Joh J; Khanal S; Husk A; Mason H; Warzecha H; Ghim SJ; Miller DM; Matoba N; Jenson AB
PLoS One; 2016; 11(8):e0160995. PubMed ID: 27518899
[TBL] [Abstract][Full Text] [Related]
17. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.
Waheed MT; Thönes N; Müller M; Hassan SW; Razavi NM; Lössl E; Kaul HP; Lössl AG
Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641
[TBL] [Abstract][Full Text] [Related]
18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
19. Production of immunogenic recombinant L1 protein of bovine papillomavirus type 9 causing teat papillomatosis.
Watanabe S; Shibahara T; Andoh K; Hatama S; Mase M
Arch Virol; 2020 Jun; 165(6):1441-1444. PubMed ID: 32239294
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of norovirus virus like particles in Escherichia coli and their immunogenicity in mice.
Huo Y; Wan X; Ling T; Wu J; Wang W; Shen S
Mol Immunol; 2018 Jan; 93():278-284. PubMed ID: 28802994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
